期刊文献+

血液透析患者肾性贫血的静脉补铁临床应用分析 被引量:4

Clinical application of intravenous iron supplementation in hemodialysis patients with renal anemia
下载PDF
导出
摘要 目的:探讨血液透析患者肾性贫血的静脉补铁临床应用效果。方法:2016年9月-2018年12月收治肾性贫血患者42例,按治疗方式不同分为两组,各21例。对照组实施右旋糖酐铁注射液治疗,试验组实施蔗糖铁注射液治疗。比较两组血清铁蛋白、血清铁浓度、转铁蛋白饱和度及总铁结合力。结果:试验组血清铁蛋白、血清铁浓度、转铁蛋白饱和度、总铁结合力均优于对照组。结论:对血液透析患者肾性贫血予以蔗糖铁注射液治疗能有效改善患者肾性贫血状况,提高治疗效果。 Objective:To explore the clinical application effect of intravenous iron supplementation in hemodialysis patients with renal anemia.Methods:From September 2016 to December 2018,42 patients with renal anemia were selected.According to different treatment methods,they were divided into two groups of 21 cases in each.The control group was treated with dextran iron injection;the experimental group was treated with sucrose iron injection.We compared the serum ferritin,serum iron concentration,transferrin saturation and total iron binding capacity between the two groups.Results:In the experimental group,serum ferritin,serum iron concentration,transferrin saturation and total iron binding capacity were better than those in the control group.the difference was statistically significant(P<0.05).Conclusion:The treatment of hemodialysis patients with renal anemia with sucrose iron injection can effectively improve the status of renal anemia and improve the therapeutic effect.
作者 张晓红 Zhang Xiaohong(Hemodialysis Room,Changsheng Hemodialysis Center of Tangshan City,Hebei Province,Hebei Tangshan 063000)
出处 《中国社区医师》 2020年第7期45-45,47,共2页 Chinese Community Doctors
关键词 血液透析 肾性贫血 蔗糖铁注射液 右旋糖酐铁注射液 Hemodialysis Renal anemia Sucrose iron injection Dextran iron injection
  • 相关文献

参考文献4

二级参考文献22

  • 1倪兆慧,钱家麒,丁小强,梅长林,袁伟杰,张金元,陈江华,邢昌赢,刘必成.蔗糖铁注射液治疗维持性血液透析患者肾性贫血的前瞻性、随机对照多中心研究[J].中华肾脏病杂志,2006,22(3):143-148. 被引量:114
  • 2王海燕 主译.慢性肾脏病及透析的临床实践指南[M].北京:人民卫生出版社,2003.69-75.
  • 3Drūeke Tilman,Witko Sarsat Véronique,Massy Ziad,et al.Iron therapy,advanced oxidation protein products,and carotid artery intima-media thickness in end stage renal disease[J].Circulation,2012,106:2212-2217.
  • 4Yoshimura Kazunobu,Nakano Hirofumi,Yokoyama Keitaro,et al.High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis[J].Clin Exp Nephrol,2010,9:158-163.
  • 5Agarwal R,Vasavada N,Sachs NG,et al.Oxidative st ress and renal injury wit h int ravenous iron in patient s wit h chronic kidney disease[J].Kidney Int,2009,65:2279-2289.
  • 6K/DOQI,National Kindey Foundation.K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease[J].Am J Kidney Dis,2006,47(5 Suppl3):S11-145.
  • 7Li H,Wang SX.Intravenous iron sucrose in peritoneal dialysis patients with renal anemia[J].Perit Dial Int,2008,28(2):149-54.
  • 8Van Wyck DB.Labile iron:manifestations and clinical implications[J].Am Soc Nephrol,2009,15(12):107-111.
  • 9Anraku M,Kitamura K,Shintomo R,et al.Effect of intravenous iron administ ration f requency on AOPP and inflammatory biomarkers in chronic hemodialysis patient s:A pilot study[J].Clinical Biochemistry,2008,41(14-15):1168-74.
  • 10康萍,罗家琳,张洪波.左卡尼丁对维持性血液透析患者微炎症状态影响的研究[J].黑龙江医药,2008,21(3):90-91. 被引量:7

共引文献9

同被引文献33

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部